Published in J Am Coll Cardiol on February 18, 2004
CoreValve® System Australia/New Zealand Clinical Study | NCT01015612
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Development of off-pump mitral valve replacement in a porcine model. Ann Thorac Surg (2015) 1.38
Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol (2011) 1.22
Dual source multidetector CT-angiography before Transcatheter Aortic Valve Implantation (TAVI) using a high-pitch spiral acquisition mode. Eur Radiol (2011) 1.09
Midterm results of transapical aortic valve replacement via real-time magnetic resonance imaging guidance. J Thorac Cardiovasc Surg (2009) 1.03
Indication for percutaneous aortic valve implantation. Arch Med Sci (2010) 1.00
Closed bore XMR (CBXMR) systems for aortic valve replacement: active magnetic shielding of x-ray tubes. Med Phys (2009) 0.92
Sutureless mitral valve replacement: initial steps toward a percutaneous procedure. Ann Thorac Surg (2013) 0.90
Remodelling of the aortic root in severe tricuspid aortic stenosis: implications for transcatheter aortic valve implantation. Eur Radiol (2009) 0.88
Technique of transcatheter aortic valve implantation with the Edwards-Sapien heart valve using the transfemoral approach. Herz (2009) 0.87
Temporary support with Tandemheart pVAD during percutaneous aortic valve replacement in an animal model: rationale and methodology. Tex Heart Inst J (2005) 0.87
Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility. J Cardiovasc Magn Reson (2013) 0.85
Percutaneous ventricular assist during aortic valvuloplasty: potential application to the deployment of aortic stent-valves. Tex Heart Inst J (2007) 0.83
Endovascular treatment of internal carotid and vertebral artery aneurysms using a novel pericardium covered stent. Interv Neuroradiol (2012) 0.82
Balloon expandable transcatheter aortic valve implantation with or without pre-dilation of the aortic valve - rationale and design of a multicenter registry (EASE-IT). BMC Cardiovasc Disord (2014) 0.80
Clinical trial experience with transcatheter aortic valve insertion. Int J Cardiovasc Imaging (2011) 0.80
Transcatheter aortic valve implantation. Surg Today (2014) 0.80
Transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis of randomised and non-randomised trials. Open Heart (2014) 0.79
Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2013) 0.78
The Nordic aortic valve intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: study protocol for a randomised controlled trial. Trials (2013) 0.78
Emerging approaches of transcatheter valve repair/insertion. Cardiol Res Pract (2010) 0.78
Percutaneous aortic valve implantation: the anesthesiologist perspective. HSR Proc Intensive Care Cardiovasc Anesth (2009) 0.77
MDCT evaluation of aortic root and aortic valve prior to TAVI. What is the optimal imaging time point in the cardiac cycle? Eur Radiol (2015) 0.77
Clinical efficacy of transcatheter aortic valve replacement for severe aortic stenosis in high-risk patients: the PREVAIL JAPAN trial. Surg Today (2014) 0.77
Classical methods to measure aortic valve area in the era of new invasive therapies: still accurate enough? Int J Cardiovasc Imaging (2008) 0.77
[Transcatheter-based aortic valve implantation. Present and future technologies]. Herz (2009) 0.77
Major innovations and trends in the medical device sector. Acta Inform Med (2012) 0.77
The change in mitral regurgitation severity after trans-catheter aortic valve implantation. J Saudi Heart Assoc (2014) 0.77
Aortic valve replacement vs. transcatheter aortic valve implantation: Patient selection. Ann Cardiothorac Surg (2012) 0.76
Comparison of Manual and Automated Preprocedural Segmentation Tools to Predict the Annulus Plane Angulation and C-Arm Positioning for Transcatheter Aortic Valve Replacement. PLoS One (2016) 0.75
Evaluation of embolic deflection device using optical particle tracking. Proc SPIE Int Soc Opt Eng (2013) 0.75
Sudden Death After Transcatheter Aortic Valve Implantation. Are Bradyarrhythmias Always The Cause? J Atr Fibrillation (2015) 0.75
The effect of X-ray beam distortion on the Edwards Sapien XT(™) trans-catheter aortic valve replacement prosthesis. J Med Radiat Sci (2015) 0.75
Transcatheter percutaneous aortic valve implantation: The dream has become a reality. Ann Saudi Med (2010) 0.75
Percutaneous aortic valve implantation: a case report. Can J Cardiol (2006) 0.75
The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature. Cardiol Ther (2012) 0.75
Multidisciplinary team approach for identifying potential candidate for transcatheter aortic valve implantation. Yonsei Med J (2014) 0.75
The next revolution: percutaneous aortic valve replacement. Rambam Maimonides Med J (2010) 0.75
Transcatheter aortic valve implantation: our experience and review of the literature. Balkan Med J (2012) 0.75
Initial experiences of young cardiologists with balloon-expandable transcatheter aortic valve implantation in Turkey: a case series of eleven patients. Eurasian J Med (2013) 0.75
Evolution of endovascular treatment for complex thoracic aortic disease. Ann Vasc Dis (2008) 0.75
In vitro study of coronary flow occlusion in transcatheter aortic valve implantation. J Thorac Dis (2014) 0.75
Transcatheter aortic valve replacement in high risk patients with different anaesthetic techniques. HSR Proc Intensive Care Cardiovasc Anesth (2010) 0.75
Semiautomatic, Quantitative Measurement of Aortic Valve Area Using CTA: Validation and Comparison with Transthoracic Echocardiography. Biomed Res Int (2015) 0.75
The impact of transcatheter aortic valve implantation on left ventricular performance and wall thickness - single-centre experience. Postepy Kardiol Interwencyjnej (2015) 0.75
A new type of aortic valved stent with good stability and no influence on coronary artery. J Cardiothorac Surg (2013) 0.75
Transaortic transcatheter aortic valve implantation - rationale and design of the multicenter, multinational prospective ROUTE registry. BMC Cardiovasc Disord (2014) 0.75
Technological solutions for cardiac surgery in the elderly. Rambam Maimonides Med J (2013) 0.75
Echocardiographic Assessment of Heart Valve Prostheses. J Cardiovasc Echogr (2017) 0.75
The Odyssey of TAVR from concept to clinical reality. Tex Heart Inst J (2014) 0.75
The development of transcatheter aortic valve replacement (TAVR). Glob Cardiol Sci Pract (2016) 0.75
Increased mortality from complications of pulmonary hypertension in patients undergoing transcatheter aortic valve replacement. Pulm Circ (2017) 0.75
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation (2002) 8.51
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (2007) 6.77
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med (2015) 6.28
Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27
Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med (2015) 5.90
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol (2004) 5.67
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol (2012) 4.29
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet (2012) 4.02
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol (2004) 3.67
Long-term outcome of percutaneous coronary intervention for chronic total occlusions. JACC Cardiovasc Interv (2011) 3.38
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29
Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med (2012) 2.88
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78
Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization. JACC Cardiovasc Interv (2013) 2.75
Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol (2012) 2.56
Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol (2008) 2.54
Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation (2002) 2.53
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol (2005) 2.42
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation (2009) 2.40
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation (2004) 2.35
A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. JACC Cardiovasc Interv (2009) 2.30
Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol (2006) 2.16
Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol (2006) 2.12
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention. J Invasive Cardiol (2010) 2.10
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ (2008) 2.09
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv (2012) 2.08
Cause of death with bare metal and sirolimus-eluting stents. Eur Heart J (2006) 2.04
Acute aortic syndrome: a 'last glance' before incision. Interact Cardiovasc Thorac Surg (2010) 2.01
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99
Surgical aortic valve replacement after percutaneous aortic valve implantation: what have we learned? J Thorac Cardiovasc Surg (2008) 1.99
Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol (2002) 1.95
The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol (2010) 1.90
Medical device development: from prototype to regulatory approval. Circulation (2004) 1.90
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation (2009) 1.88
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation (2004) 1.87
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol (2004) 1.84
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation (2004) 1.83
Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv (2010) 1.81
Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol (2012) 1.80
Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation (2011) 1.79
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol (2013) 1.79
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol (2003) 1.77
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol (2005) 1.73
Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol (2005) 1.72
Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation (2004) 1.72
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72
Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv (2008) 1.70
Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation (2011) 1.69
Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol (2012) 1.67
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol (2012) 1.66
In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry. Eur Heart J (2008) 1.65
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial. Circulation (2005) 1.64
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J (2010) 1.63
Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era. Am J Cardiol (2011) 1.63
Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study. J Am Coll Cardiol (2003) 1.62
Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol (2013) 1.62
Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol (2004) 1.61
Evaluation of left ventricular diastolic function with cardiac MR imaging. Radiographics (2011) 1.61
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol (2012) 1.61
Aortic valve replacement after percutaneous valvuloplasty--an approach in otherwise inoperable patients. Eur J Cardiothorac Surg (2010) 1.60
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation (2005) 1.60
Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv (2012) 1.59
Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. Am J Cardiol (2006) 1.59
Drug-eluting stents: costs versus clinical benefit. Circulation (2003) 1.57
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int (2005) 1.57
Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol (2004) 1.57
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol (2006) 1.56
B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. Eur Heart J (2009) 1.56
Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation (2006) 1.56
Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry). Am J Cardiol (2009) 1.56
Dual catheter technique for the treatment of severe coronary artery perforations. Catheter Cardiovasc Interv (2010) 1.55
Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 Registry. Circ Cardiovasc Interv (2014) 1.55